Walt Downing, Chair of BioMed SA, Leonard Pinchuk, Ph.D., D.Sc., and Ann Stevens, President of BioMed SA, took part in the Sept. 13, 2017 Award for Innovation in Healthcare and Bioscience program.

BioMed SA Honors Bioengineering Innovator

September 14, 2017
By Wendy Rigby, Texas Public Radio

The nonprofit group BioMed SA chose a Florida bioengineer as the recipient of its 2017 Award for Innovation Healthcare and Bioscience. His inventions have impacted millions.

Chances are you’ve never heard of Leonard Pinchuk, Ph.D. But chances are, you or someone you know has benefited from a medical breakthrough tied to one of his more than a hundred patents.

Pinchuk traveled to San Antonio from Miami to receive his award from BioMed SA. He says his proudest accomplishment is the development of a special plastic – a new polymer that the body doesn’t recognizeas foreign. Plus, it doesn’t break down over time.

"Just a small group of us -- a handful of people -- were able to do it and beat the rest of he world to market with what became one of the largest products in the history of medicine," Pinchuk commented.

That product is a drug-coated stent – a tiny device used to hold open blocked heart arteries.

BioMed SA President Ann Stevens says Pinchuk’s innovations are used worldwide. "He actually invented the material that made the first balloon catheter used for angioplasty."

For the U.S. to continue with bioengineering success, Pinchuk said America should embrace scientists wo want to bring their talent to this country. "Perhaps it requires this influx of people who want to get away and do something. It’s actually these go-getters who tend to be the inventors. And we have to let them in," Pinchuk added.

His latest invention is a tiny microshunt – an eye implant to keep glaucoma patients from going blind.

Stay informed. Subscribe to BioMed SA news alerts.

BioMed SA is a non-profit, membership-based organization, supported in part by the City of San Antonio. Links provided from the BioMed SA website to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.